The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...

Current treatment for bedaquiline-resistant tuberculosis is linked with poor microbiological responses, unfavorable clinical ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

DOH Usec. Abdullah B. Dumama Jr, Cluster Lead of the National UHC Health Services Cluster (UHC-HSC) and concurrent head of ...

Physicians who champion immunization sustain herd immunity, reducing the incidence of severe diseases, hospitalizations, and ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...

DeepTek’s AI-based chest X-ray solution meets WHO performance standards for computer-aided detection in tuberculosis ...

There are many things we’ve learned from studying the ancient Egyptians. One especially fascinating discovery was evidence of ...

Tamil Nadu integrates predictive model to reduce TB deaths, prioritizing severely ill patients for prompt hospital admission.

Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...

Tuberculosis remains a major health challenge in South Africa, but professional nurse Nhlanhla Mofokeng is determined to change that through education, compassion, and community support.